Peregrine Ventures, Israel's leading venture capital fund focuses on early stage investments, invests in promising High-Tech companies with a strong emphasis on Life Sciences, Digital Health and Information Technology.

Peregrine Ventures, Israel's leading venture capital fund, invests in promising early stage high-tech companies with a strong emphasis on Life Sciences, Digital Health and Information Technology.

Operating since 2001

Over 500 ideas screened per year

Experienced team

Market driven

Collaborating with talented entrepreneurs, Peregrine has earned a solid reputation for turning innovative technologies into successful companies with significant global presence. 

Read more>>

Portfolio Companies


Management Team

Peregrine's success can be ascribed to the vast experience and professionalism of our management team. Comprised of seasoned entrepreneurs from leading technology companies, our management team is well connected to the tech scene and committed to supporting the Fund`s array of unique portfolio companies.

Eyal Lifschitz

Managing General Partner


Boaz Lifschitz

Managing General Partner

Tamir Tal

Venture Partner

Lior Shahory

General Partner

Tal Carasso

Venture Partner, Director of Investor Relations

David Eldar



Prior to sending us your business plan, please read through the Evaluation Criteria & Process, 
and Submit a Business Plan section.

Latest News

September 17, 2020

REHOVOT, Israel, Sept. 17, 2020 /PRNewswire/ -- Raziel Therapeutics, a Pharmaceutical company developing next-generation novel prescription products for the medical aesthetics market announces licensing of its disruptive technology, RZL-012, to Fosun Pharma for milesto...

December 9, 2019

CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today that the external and independent Endpoint Adjudication Committee (EAC) performed the first Interim Analysis (IA) on th...

October 15, 2019

KFAR SABA, Israel, Oct. 15, 2019 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the first implantation of the Agili-C™ implant, as part of Investigati...

October 7, 2019

New WhiteSource for Developers integrations with GitLab Core and Eclipse IDE empower even more enterprise developers to create secure products faster.

Read more


October 3, 2019

Based in Rehovot, the medical device company has developed a proprietary 355nm wavelength laser technology platform.

US medical device company AngioDynamics Inc. (NASDAQ: ANGO) today announced an agreement to acquire Israel laser technology developer Eximo Medical Ltd....

September 20, 2019


A typical lettings agent could save some two and a half hours’ time each working day if they adopted more Artificial Intelligence to take over routine tasks. 

That’s the view of virtual assistant which says its time saving estimate is conservative if agents all...

May 23, 2019

TEL AVIV, Israel, May 23, 2019 /PRNewswire/ -- WhiteSource, the leader in open source security and license compliance management, announced today a partnership with GitHub, the leading software development platform, to help developers more easily detect open...

March 28, 2019

תחרות על עובדים מוכשרים בענף ההייטק גוברת. במסגרת סדרת הראיונות של ערוץ הייטקיסט עם מנהלים בארגונים, מצאו אנשי "כלכליסט" כי עבור טאלנטים, הבחירה במקום העבודה הבא מבוססת על הרבה מעבר לתלוש השכר. ראיון עם  יונתן שניר, מנכ״ל ומייסד שותף בחברת קליקלאפ.

קראו ע...

January 28, 2019

TEHOVOT, Israel--(BUSINESS WIRE)--Eximo Medical Ltd., announced today the successful launch and first commercial use of the B-Laser™ Atherectomy System for treatment of peripheral vascular disease. Dr. Barry Weinstock of Orlando Heart & Vascular Institute, director of...

October 17, 2018

TEL AVIV, Israel, Oct. 17, 2018 /PRNewswire/ — WhiteSource, the leader in continuous open source security management, announced a $35 million funding round led by Susquehanna Growth Equity, with participation by existing investors 83North and M12 – Microsoft Ventures....

Older Posts >

Please reload



Your partner for early stage investments.

Leading edge

Leading edge

Technology innovation is an integral part of our vision.

Spread your wings

Spread your wings

The sky is the limit. Dream big.

Life science  innovation

Life science innovation

Join us

Join us

Together we can make your ideas grow.



We believe in supporting non-profit community and social welfare organizations.
The following are some of the projects we are involved with.


Matan is a leading Israeli nonprofit organization promoting a caring civil society by advising corporations, individual donors and foundations on effective community investments and implementation. For more information, please contact Matan.


Tmura - The Israeli Public Service Venture Fund, a foundation with a unique business model, was established in 2002 by leading Israeli venture capital funds to involve the high-tech sector in supporting charitable activities. The model is simple: early-stage companies give Tmura a warrant, convertible (at exit) into a small portion of their equity. If the company succeeds, Tmura sells its shares and donates the proceeds to charities in Israel; the focus is on education and youth-related activities, and the companies can indicate which organizations they want to support.


Peregrine Ventures, as well as several other leading venture capital funds, support Tmura's activities and encourage portfolio companies to make an equity donation to Tmura. For more information, please contact Tmura.


Your Partner for EarlyStage Investments.

Contact Info

6 Yoni Netanyahu Street
Or Yehuda, 60376, Israel

Phone: +972 -3- 634 9990 
Fax: +972 -3- 634 9910


Map & Directions >>


Life Sciences




© Peregrine Ventures  |  Terms & Conditions  |  Privacy Policy